NCT05840913View on ClinicalTrials.gov

Different Volumes of Articaine for Inferior Alveolar Nerve Block in Irreversible Pulpitis

PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Drug EffectPulpitis - Irreversible
Interventions
DRUG

Articaine HCl 4 % / EPINEPHrine 1:100,000 in 1.8 mL Dental Cartridge

Local anesthetic injection for intra- operative pain control

Trial Locations (2)

46000

Armed Forces Institue Of Dentistry, Rawalpindi

Armed Forces Institute of Dentistry, Rawalpindi

All Listed Sponsors
lead

Armed Forces Institute of Dentistry, Pakistan

OTHER

NCT05840913 - Different Volumes of Articaine for Inferior Alveolar Nerve Block in Irreversible Pulpitis | Biotech Hunter | Biotech Hunter